| Attribute |
Value |
| 52 Week Change |
-0.2315436 |
| Address1 |
5,217 Winnebago Lane |
| All Time High |
32.5 |
| All Time Low |
2.09 |
| Ask |
2.96 |
| Ask Size |
2 |
| Average Daily Volume10 Day |
39,650 |
| Average Daily Volume3 Month |
30,442 |
| Average Volume |
30,442 |
| Average Volume10Days |
39,650 |
| Beta |
0.844 |
| Bid |
1.65 |
| Bid Size |
2 |
| Book Value |
4.429 |
| City |
Austin |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
2.31 |
| Current Ratio |
39.029 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,782,777,600 |
| Day High |
2.31 |
| Day Low |
2.28 |
| Display Name |
XBiotech |
| Dividend Date |
1,626,998,400 |
| Earnings Timestamp End |
1,755,259,200 |
| Earnings Timestamp Start |
1,754,909,940 |
| Ebitda |
-46,833,000 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
0.975 |
| Enterprise Value |
-45,642,096 |
| Eps Forward |
0.13 |
| Eps Trailing Twelve Months |
-1.31 |
| Esg Populated |
0 |
| Ex Dividend Date |
1,626,307,200 |
| Exchange |
NMS |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fax |
512 386 5505 |
| Fifty Day Average |
2.3928 |
| Fifty Day Average Change |
-0.08280015 |
| Fifty Day Average Change Percent |
-0.03460387 |
| Fifty Two Week Change Percent |
-23.15436 |
| Fifty Two Week High |
3.61 |
| Fifty Two Week High Change |
-1.3 |
| Fifty Two Week High Change Percent |
-0.3601108 |
| Fifty Two Week Low |
2.09 |
| Fifty Two Week Low Change |
0.22000003 |
| Fifty Two Week Low Change Percent |
0.10526317 |
| Fifty Two Week Range |
2.09 - 3.61 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,429,104,600,000 |
| Float Shares |
22,837,750 |
| Forward Eps |
0.13 |
| Forward P E |
17.769232 |
| Free Cashflow |
-30,622,624 |
| Full Exchange Name |
NasdaqGS |
| Full Time Employees |
87 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.0 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.24327 |
| Held Percent Institutions |
0.06814 |
| Implied Shares Outstanding |
30,487,731 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Dividend Date |
1,626,307,200 |
| Last Dividend Value |
2.5 |
| Last Fiscal Year End |
1,767,139,200 |
| Long Business Summary |
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas. |
| Long Name |
XBiotech Inc. |
| Market |
us_market |
| Market Cap |
70,426,656 |
| Market State |
REGULAR |
| Max Age |
86,400 |
| Message Board Id |
finmb_216818432 |
| Most Recent Quarter |
1,774,915,200 |
| Net Income To Common |
-40,161,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
69,816,903 |
| Open |
2.31 |
| Operating Cashflow |
-42,169,000 |
| Operating Margins |
0.0 |
| Payout Ratio |
0.0 |
| Phone |
512 386 2900 |
| Previous Close |
2.29 |
| Price Hint |
4 |
| Price To Book |
0.52156246 |
| Profit Margins |
0.0 |
| Quick Ratio |
38.6 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
0.01999998 |
| Regular Market Change Percent |
0.87336165 |
| Regular Market Day High |
2.31 |
| Regular Market Day Low |
2.28 |
| Regular Market Day Range |
2.28 - 2.31 |
| Regular Market Open |
2.31 |
| Regular Market Previous Close |
2.29 |
| Regular Market Price |
2.31 |
| Regular Market Time |
1,784,132,012 |
| Regular Market Volume |
16,217 |
| Return On Assets |
-0.1881 |
| Return On Equity |
-0.25933 |
| Sand P52 Week Change |
0.2043345 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
30,487,731 |
| Shares Percent Shares Out |
0.009 |
| Shares Short |
275,570 |
| Shares Short Previous Month Date |
1,780,012,800 |
| Shares Short Prior Month |
181,275 |
| Short Name |
XBiotech Inc. |
| Short Percent Of Float |
0.0106 |
| Short Ratio |
8.41 |
| Source Interval |
15 |
| State |
TX |
| Symbol |
XBIT |
| Total Cash |
115,459,000 |
| Total Cash Per Share |
3.787 |
| Total Debt |
0 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-1.31 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
2.43495 |
| Two Hundred Day Average Change |
-0.12495017 |
| Two Hundred Day Average Change Percent |
-0.05131529 |
| Type Disp |
Equity |
| Volume |
16,217 |
| Website |
https://www.xbiotech.com |
| Zip |
78,744 |